Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma. Blood Adv. 2023 07 11; 7(13):2983-2993.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Humans
Lymphoma, Mantle-Cell
Neoplasm Recurrence, Local
Tumor Lysis Syndrome
authors with profiles
Peter Riedell